WELCOME
Fresenius Kabi AG is a 100% subsidiary of the health care group Fresenius SE & Co. KGaA. Fresenius Kabi is the leader in infusion therapy and clinical nutrition in Europe and in its most important countries of Latin America and Asia Pacific. Within I.V. generic drugs, Fresenius Kabi counts among the leading suppliers in the U.S. market. In addition to offices in major centres throughout South Africa including Johannesburg, Cape Town, Durban and Bloemfontein, the company also has a manufacturing plant in Port Elizabeth with the company headquarters and marketing/distribution centre in Midrand, Johannesburg.
All over the world more than 24 000 employees are committed to improving the quality of life of critically and chronically ill patients with innovative products for patients in hospitals and outpatients.